Nevirapine Resistance Study: Nevirapine Resistance Among HIV-Infected Mothers
NCT00164762 is an observational study sponsored by Centers for Disease Control and Prevention. As of 21 Nov 2026, it is completed. It studies HIV Infections. The registry lists an enrollment of 126 participants at 1 site in 1 country. The registry lists a start date of 30 Jun 2005. One of its registered investigators has a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT00164762 |
| Status | Completed |
| Study type | Observational study |
| Lead sponsor | Centers for Disease Control and Prevention |
| Enrollment | 126 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | HIV Infections |
| Start | 30 Jun 2005 |
| Study completion | 30 Nov 2006 |
| Last update posted | 1 Oct 2007 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Charles Van der Horst, MD
University of North Carolina, Chapel Hill
Principal Investigator - Denise J Jamieson, MD, MPH
Centers for Disease Control and Prevention
Principal InvestigatorKOL profile → - Peter Kazembe, MB ChB
Kamuzu Central Hospital
Principal Investigator - Sherry L Farr, PhD
Centers for Disease Control and Prevention
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Area 25 Health Center
Lilongwe
Sites by country
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT00164762
Each answer restates registry values shown on this page.
What is NCT00164762?
NCT00164762 is an observational study sponsored by Centers for Disease Control and Prevention. It studies HIV Infections.
Who leads NCT00164762?
The registry names Charles Van der Horst, MD (principal investigator, University of North Carolina, Chapel Hill), Denise J Jamieson, MD, MPH (principal investigator, Centers for Disease Control and Prevention), Peter Kazembe, MB ChB (principal investigator, Kamuzu Central Hospital) and 1 more official as overall officials.
Where does NCT00164762 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: Malawi.
When did NCT00164762 end?
The registry lists a study completion date of 30 Nov 2006. The sponsor last updated the record on 1 Oct 2007.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.